|
PTGES3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.191600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.725800E-01 |
| Normal-vs-Stage2 |
4.962800E-01 |
| Normal-vs-Stage3 |
1.321640E-02 |
| Normal-vs-Stage4 |
9.200800E-03 |
| Stage1-vs-Stage2 |
6.434200E-01 |
| Stage1-vs-Stage3 |
7.535600E-03 |
| Stage1-vs-Stage4 |
1.448740E-04 |
| Stage2-vs-Stage3 |
1.314990E-01 |
| Stage2-vs-Stage4 |
5.556900E-03 |
| Stage3-vs-Stage4 |
1.199390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.872500E-02 |
| Normal-vs-AfricanAmerican |
1.154640E-01 |
| Normal-vs-Asian |
4.186200E-01 |
| Caucasian-vs-AfricanAmerican |
8.216000E-01 |
| Caucasian-vs-Asian |
4.478000E-01 |
| AfricanAmerican-vs-Asian |
4.683000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.783000E-01 |
| Normal-vs-Female |
2.475500E-03 |
| Male-vs-Female |
1.061720E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.717600E-01 |
| Normal-vs-Extreme_Weight |
5.520600E-01 |
| Normal-vs-Obese |
6.295800E-02 |
| Normal-vs-Extreme_Obese |
3.696000E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.714400E-01 |
| Normal_Weight-vs-Obese |
5.018800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.391900E-02 |
| Extreme_Weight-vs-Obese |
2.002400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.741700E-02 |
| Obese-vs-Extreme_Obese |
1.819560E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.481800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.639900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.647600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.561400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.161500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.811000E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.249710E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.414430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.476600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.817800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.697560E-01 |
| Normal-VS-Type2 PRCC |
6.639600E-01 |
| Normal-VS-KIRP CIMP |
9.843200E-04 |
| Normal-VS-Unclassified PRCC |
1.864780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.550200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.31679994580725E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
5.094000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.14139999995988E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
3.411400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.978400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.941800E-01 |
| Normal-vs-N1 |
1.772120E-04 |
| Normal-vs-N2 |
1.206770E-01 |
| N0-vs-N1 |
4.23080000000464E-06 |
| N0-vs-N2 |
7.362800E-03 |
| N1-vs-N2 |
8.726800E-01 |
|
|
